SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
sg
Lv2
5
150 积分
2023-09-26 加入
最近求助
最近应助
互助留言
PI3K signaling-regulated metabolic reprogramming: From mechanism to application
1天前
待确认
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
3天前
已完结
Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study
3天前
已关闭
Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study
3天前
已关闭
Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study
3天前
已关闭
Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study
3天前
已关闭
Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology
17天前
已完结
Cervical cancer prevention in China: a key to cancer control
26天前
已完结
Thelandscapeofcancer research and cancer care inChina
26天前
已完结
The efficacy and safety of tacrolimus in patients with dermatomyositis/polymyositis: A meta-analysis and systematic review
1个月前
已完结
没有进行任何应助
未找到【积分已退回】
3天前
缺少内容
3天前
内容不对【积分已退回】
3天前
文献缺页
3天前
未找到【积分已退回】
3天前
缺少内容
3天前
已找到【积分已退回】
3天前
文章内容不全
3天前
已找到【积分已退回】
5个月前
感谢
10个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论